Chronic urticaria – new views on diagnosis and treatment of disease
Authors:
Dana Prusíková
Authors place of work:
Dermatovenerologická klinika 3. LF UK a FNKV, Praha
Published in the journal:
Čas. Lék. čes. 2017; 156: 123-126
Category:
Review Article
Summary
Interest in chronic urticaria has grown in recent years, largely owing to the advent of new modes treatment especially in the form of the biologic preparation omalizumab. New scientific and clinical findings have not only facilitated a more comprehensive view of the disease but have streamlined the classification and diagnostic approach as well. Diagnostics are no longer burdened by cumbersome and lengthy investigative procedures into the etiology of urticaria, but are much more rapid and targeted bringing about more timely relief of the patient's symptoms. According to recent data, the impact of the illness onto the quality of life of the patient, especially in those with more severe forms of urticaria, can be quite devastating both physically and psychologically compared to other chronic diseases (e.g. coronary artery disease, etc.).
Keywords:
chronic spontaneous urticaria, UAS7 score, omalizumab
Zdroje
1. Benáková N. Současné praktické postupy pro vyšetřování a léčbu chronické urtikárie. Aktualizovaný přehled a interpretace doporučených postupů v praxi. Česko-slovenská dermatologie 2015; 5: 198–212.
2. Zuberbier T, Aberer W, Asero R et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis and management of urticaria: the 2013 revision and update. Allergy 2014; 7: 868–887.
3. Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki BM. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol 1995; 75: 484–487.
4. Alexandrová P, Zelenková D, Hercogová J. Akutní a chronická kopřivka (klasifikace, diagnostika, léčba): souhrn z doporučených postupů pro diagnostiku a léčbu urtikárie (podle EAACI/GA2LEN/EDF/WAO), upraveno pro použití v ČR dle SÚKL. Česká dermatovenerologie 2015; 5(2): 100–106.
5. Mauer M, Church MK, Gonçalo M et al. Management and treatment of chronic urticaria. J Eur Acad Dermatol Venereol 2015; 29(Suppl 3): 16–32.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Basal cell carcinoma and the modalities of its therapy
- Diseases affecting the scalp
- Hirsutism – etiopathogenesis, diagnostics and treatment
- Androgenetic alopecia in women